149 related articles for article (PubMed ID: 24916285)
1. Terminated.
Rosendaal FR; Reitsma PH
J Thromb Haemost; 2014 Jun; 12(6):813. PubMed ID: 24916285
[No Abstract] [Full Text] [Related]
2. Clinical trials and tribulations.
Greaves M
J Thromb Haemost; 2014 Jun; 12(6):822-3. PubMed ID: 24655890
[No Abstract] [Full Text] [Related]
3. Comparison of idrabiotaparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: the Borealis-Atrial Fibrillation Study.
Buller HR; Halperin J; Hankey GJ; Pillion G; Prins MH; Raskob GE
J Thromb Haemost; 2014 Jun; 12(6):824-30. PubMed ID: 24597472
[TBL] [Abstract][Full Text] [Related]
4. Stroke prevention in atrial fibrillation: another step sideways.
Go AS; Singer DE
Lancet; 2008 Jan; 371(9609):278-80. PubMed ID: 18294981
[No Abstract] [Full Text] [Related]
5. Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial.
; Bousser MG; Bouthier J; Büller HR; Cohen AT; Crijns H; Davidson BL; Halperin J; Hankey G; Levy S; Pengo V; Prandoni P; Prins MH; Tomkowski W; Torp-Pedersen C; Wyse DG
Lancet; 2008 Jan; 371(9609):315-21. PubMed ID: 18294998
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Bioprosthetic Valves.
Kheiri B; Przybylowicz R; Simpson TF; Alhamoud H; Osman M; Dalouk K; Nazer B; Henrikson CA; Stecker E
Am J Cardiol; 2021 Mar; 142():140-141. PubMed ID: 33285096
[No Abstract] [Full Text] [Related]
7. [Atrial fibrillation: new anticoagulants are more effective and safer, but expensive].
Steurer J
Praxis (Bern 1994); 2014 Jun; 103(13):785-6. PubMed ID: 24938162
[No Abstract] [Full Text] [Related]
8. Apixaban versus warfarin in atrial fibrillation.
Vassiliou VS
N Engl J Med; 2012 Jan; 366(1):88; author reply 89. PubMed ID: 22216849
[No Abstract] [Full Text] [Related]
9. Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Left Ventricular Hypertrophy: Insights From the ARISTOTLE Trial.
Al-Khatib SM; Mulder H; Wojdyla D; Lopes RD; Wallentin L; Alexander JH; Hijazi Z; Goto S; Granger CB
Circ Arrhythm Electrophysiol; 2021 Mar; 14(3):e009614. PubMed ID: 33657831
[No Abstract] [Full Text] [Related]
10. New anticoagulants for atrial fibrillation.
Sobieraj-Teague M; O'Donnell M; Eikelboom J
Semin Thromb Hemost; 2009 Jul; 35(5):515-24. PubMed ID: 19739042
[TBL] [Abstract][Full Text] [Related]
11. Ximelagatran or warfarin in atrial fibrillation?
Stöllberger C; Finsterer J
Lancet; 2004 Feb; 363(9410):734-5; author reply 736. PubMed ID: 15001336
[No Abstract] [Full Text] [Related]
12. Edoxaban for reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation.
Dzeshka MS; Lip GY
Expert Opin Pharmacother; 2015; 16(17):2661-78. PubMed ID: 26559069
[TBL] [Abstract][Full Text] [Related]
13. Will direct oral anticoagulants completely replace warfarin?
Thachil J
Br J Hosp Med (Lond); 2018 Nov; 79(11):604-605. PubMed ID: 30418820
[No Abstract] [Full Text] [Related]
14. [Not Available].
Juhlin T
Lakartidningen; 2018 Dec; 115():. PubMed ID: 30512137
[No Abstract] [Full Text] [Related]
15. Clinical practice. Care of patients receiving long-term anticoagulant therapy.
Schulman S
N Engl J Med; 2003 Aug; 349(7):675-83. PubMed ID: 12917305
[No Abstract] [Full Text] [Related]
16. Oral anticoagulants for Asian patients with atrial fibrillation.
Sabir I; Khavandi K; Brownrigg J; Camm AJ
Nat Rev Cardiol; 2014 May; 11(5):290-303. PubMed ID: 24614113
[TBL] [Abstract][Full Text] [Related]
17. Renal Function in Atrial Fibrillation: A Multifaceted Dilemma.
Hijazi Z; Wallentin L
Circulation; 2016 Jul; 134(1):48-51. PubMed ID: 27358436
[No Abstract] [Full Text] [Related]
18. The impact of inpatient rivaroxaban versus warfarin on hospital-based outcomes when used for stroke prevention in patients with anticoagulant naïve, new-onset nonvalvular atrial fibrillation.
Hurley C; Dai S; Sobieraj DM
Int J Cardiol; 2015 Aug; 192():1-2. PubMed ID: 25981569
[No Abstract] [Full Text] [Related]
19. [Treatment with oral anticoagulants in older patients: Should warfarin still be prescribed?].
Lafuente-Lafuente C; Oasi C; Belmin J
Presse Med; 2019 Feb; 48(2):154-164. PubMed ID: 30528147
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort study.
Maura G; Blotière PO; Bouillon K; Billionnet C; Ricordeau P; Alla F; Zureik M
Circulation; 2015 Sep; 132(13):1252-60. PubMed ID: 26199338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
